Publications by authors named "Joseph Payne"

Claim this Profile
M
Modified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against .
Anand Chakroborty, Deiniol R Pritchard, Marc E Bouillon, Anna Cervi, Rolf Kraehenbuehl, Joseph Payne

Pharmaceutics· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flukicidal effects of abietane diterpenoid derived analogues against the food borne pathogen Fasciola hepatica.
Anand Chakroborty, Deiniol Pritchard, Marc E Bouillon, Anna Cervi, Alan Cookson, Joseph Payne

Vet Parasitol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function.
Gretchen Wolff, Minako Sakurai, Amit Mhamane, Maria Troullinaki, Adriano Maida, Joseph Payne

Mol Metab· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of two wild castor (Ricinus communis L.) accessions for cadmium tolerance in relation to antioxidant systems and lipid peroxidation.
Akwasi Yeboah, Jiannong Lu, Shuailei Gu, Haiyan Liu, Yuzhen Shi, Joseph Payne

Environ Sci Pollut Res Int· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Property-Driven Design and Development of Lipids for Efficient Delivery of siRNA.
Kumar Rajappan, Steven P Tanis, Rajesh Mukthavaram, Scott Roberts, Michelle Nguyen, Joseph E Payne

J Med Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune modulatory nanoparticle therapeutics for intracerebral glioma.
Nasser K Yaghi, Jun Wei, Yuuri Hashimoto, Ling-Yuan Kong, Konrad Gabrusiewicz, Joseph E Payne

Neuro Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A low frequency persistent reservoir of a genomic island in a pathogen population ensures island survival and improves pathogen fitness in a susceptible host.
Helen C Neale, Robert Laister, Joseph Payne, Gail Preston, Robert W Jackson

Environ Microbiol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of KLYP961, a dual inhibitor of inducible and neuronal nitric-oxide synthases.
Kent T Symons, Phan M Nguyen, Mark E Massari, John V Anzola, Lena M Staszewski, Joseph E Payne

J Pharmacol Exp Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models.
Joseph E Payne, Céline Bonnefous, Kent T Symons, Phan M Nguyen, Marciano Sablad

J Med Chem· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerization.
Kent T Symons, Mark E Massari, Phan M Nguyen, Tom T Lee, Jeffrey Roppe, Joseph E Payne

Mol Pharmacol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists.
Richard A Hartz, Vijay T Ahuja, Argyrios G Arvanitis, Maria Rafalski, Eddy W Yue, Joseph Payne

J Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-frequency performance of submicrometer transistors that use aligned arrays of single-walled carbon nanotubes.
Coskun Kocabas, Simon Dunham, Qing Cao, Kurt Cimino, Xinning Ho, Joseph Payne

Nano Lett· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.
Céline Bonnefous, Joseph E Payne, Jeffrey Roppe, Hui Zhuang, Xiaohong Chen

J Med Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of KD5170: a novel mercaptoketone-based histone deacetylase inhibitor.
Joseph E Payne, Céline Bonnefous, Christian A Hassig, Kent T Symons, Xin Guo

Bioorg Med Chem Lett· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling.
Rentian Feng, Huihui Ma, Christian A Hassig, Joseph E Payne, Nicholas D Smith

Mol Cancer Ther· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo.
Christian A Hassig, Kent T Symons, Xin Guo, Phan-Manh Nguyen, Tami Annable, Joseph E Payne

Mol Cancer Ther· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alopecia areata associated with regression of cutaneous melanoma.
Marjan Yousefi, Joseph R Payne, Raymond L Barnhill

Int J Dermatol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Water soluble prodrug of a COX-2 selective inhibitor suitable for intravenous administration in models of cerebral ischemia.
Nicholas D Smith, Thomas S Reger, Joseph Payne, Jasmine Zunic, Dan Lorrain

Bioorg Med Chem Lett· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel approach to pro-drugs of lactones: water soluble imidate and ortho-ester derivatives of a furanone-based COX-2 selective inhibitor.
Steve F Poon, Nicholas Stock, Joseph E Payne, Angela R McGuire, Brian Stearns

Bioorg Med Chem Lett· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastric necrosis associated with acute gastric dilatation and small bowel obstruction.
John L Powell, Joseph Payne, Clinton L Meyer, Paul R Moncla

Gynecol Oncol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the History of Epidemiology in England. Inaugural Address of Session 1893-94.
Joseph Frank Payne

Trans Epidemiol Soc Lond· January 1894

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On Tuberculosis as an Endemic Disease. Inaugural Address of Session 1892-93.
Joseph Frank Payne

Trans Epidemiol Soc Lond· January 1893

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis